The tumor mutation analysis results indicate significant differences in gene mutation profiles between the high-risk and low-risk groups in Fig. 8A, B. In the high-risk group, TP53 had the highest mutation frequency at 58%, followed by TTN at 42%. Here, TP53 is linked to neoplasm.